No Data
Eiken Chemical: Interim report.
Towns - The interim financial results for the period ending June 2025 confirm good performance, supporting the undervaluation of stock prices.
Towns <197A>, which has strengths in core technologies such as antibody-related technologies and "platinum-gold colloid" technology, as well as multiple development achievements of products that are the "first in the world" in the field of testing for mycobacteria such as tuberculosis, reported its interim financial results for the period ending June 2025, showing a revenue of 11,981 million yen, a 3.1% increase compared to the same period last year, and an operating profit of 6,538 million yen, an 11.7% increase, reflecting significant growth in both revenue and profit. In the second quarter alone, the figures show a revenue increase of 19.0% and a profit increase of 32.5%, indicating extremely high growth. Contributions from influenza.
Express News | [Change Report] NIPPON ACTIVE reported an increase in the Shareholding ratio of Eiken Chemicals (4549.JP) to 24.69%.
Hitachi, upward revision on March 25, operating profit 930 billion yen, up from 875 billion yen.
Hitachi <9501> announced a revision of the performance forecast for the fiscal year ending March 2025. Revenue has been revised upward from 9 trillion 150 billion yen to 9 trillion 700 billion yen, and operating profit has been increased from 875 billion yen to 930 billion yen. The revenue of its subsidiary, Hitachi Energy, engaged in power transmission and distribution networks, is growing, and the "Lumada" business that supports corporate digital transformation (DX) is also performing well. The depreciation of the yen against the Exchange Rates (1 dollar = 145 yen) is also boosting revenue. [Positive Assessment] <95
Eiken Chemical Sees FY Net Y2.62B
Eiken Chemical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)